Metaplastic breast cancer: clinicopathological features and its prognosis
Authors:
- 12 March 2012
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 65 (5) , 441-446
Abstract
Aims The prognosis of metaplastic breast cancer (MBC) is reportedly worse than that of triple-negative invasive ductal carcinoma (TN-IDC), but the determinants of poor prognosis are not yet known. Methods Patients from two Korean cancer centres were included in this study (67 MBC and 520 TN-IDC). Characteristics of the two disease groups, including clinical parameters, histological features, chemoresponsiveness, disease recurrence and survival estimates, were evaluated. Results MBC presented with larger tumours, more frequent distant metastasis and higher histological grade compared with TN-IDC (pConclusions MBC had worse survival outcomes compared with TN-IDC. Poor prognosis for MBC was likely caused by frequent recurrence with high initial stage and the unique biology of MBC itself.Keywords
This publication has 24 references indexed in Scilit:
- Metaplastic Breast Cancer: To Radiate or Not to Radiate?Annals of Surgical Oncology, 2010
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancerBreast Cancer Research and Treatment, 2010
- Breast carcinoma—rare types: review of the literatureAnnals of Oncology, 2009
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell CharacteristicsCancer Research, 2009
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerJournal of Clinical Oncology, 2008
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 2007
- Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureBreast Cancer Research and Treatment, 2006
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000